Zhejiang Taimei Medical Technology Co., Ltd. operates as a technology solution provider in the field of life sciences with a focus on clinical research and pharmacovigilance. The company is headquartered in Jiaxing, Zhejiang and currently employs 656 full-time employees. The company went IPO on 2024-10-08. The firm mainly designs and provides industry-specific software and digital services to a variety of stakeholders in the pharmaceutical and medical device industry. The firm's cloud-based software mainly provides software as a service (SaaS) products and customized products as well as related technical support, including TrialOS, a digital collaboration platform for the research and development of pharmaceutical and medical device, and PharmaOS, a digital collaboration platform for pharmaceutical and medical device commercialization. The firm's digital services mainly include digital clinical research services and independent reading center (IRC) services. The firm principally conducts its businesses in domestic and overseas markets.
02576.HK stock price ended at $4.48 on 水曜日, after rising 0.67%
On the latest trading day Jan 21, 2026, the stock price of 02576.HK rose by 0.67%, climbing from $4.48 to $4.48. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $4.48 and a high of $4.48. Alongside this price increase, trading volume also rose by 21.6K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 200 shares were traded, amounting to a market value of approximately $897.9M.
ポートフォリオ